快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
杨金坤,郑坚,沈克平,韩颖盈,顾缨,朱莹杰,周浩,赵爱光,赵海磊,杨金祖.中药胃肠安防治进展期胃癌术后转移的临床研究[J].中国中西医结合杂志,2003,(8):580-582
中药胃肠安防治进展期胃癌术后转移的临床研究
Clinical Study on Post-operative Metastasis Prevention of Progressive Stage of Gastric Cancer by Weichang′an
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  胃肠安胃癌转移临床研究
英文关键词:Weichang′an  metastasis of gastric cancer  clinical study
基金项目:国家科委重大疾病“九五”攻关项目基金资助 (No .96 90 6 0 7 0 1 )
作者单位
杨金坤 海中医药大学附属龙华医院肿瘤一科 上海200032 
郑坚 海中医药大学附属龙华医院肿瘤一科 上海200032 
沈克平 海中医药大学附属龙华医院肿瘤一科 上海200032 
韩颖盈 海中医药大学附属龙华医院肿瘤一科 上海200032 
顾缨 海中医药大学附属龙华医院肿瘤一科 上海200032 
朱莹杰 海中医药大学附属龙华医院肿瘤一科 上海200032 
周浩 海中医药大学附属龙华医院肿瘤一科 上海200032 
赵爱光 海中医药大学附属龙华医院肿瘤一科 上海200032 
赵海磊 海中医药大学附属龙华医院肿瘤一科 上海200032 
杨金祖 海中医药大学附属龙华医院肿瘤一科 上海200032 
摘要点击次数: 1355
全文下载次数: 2119
中文摘要:
      目的 :观察中药胃肠安对进展期胃癌术后转移的影响。方法 :采用前瞻性随机分组对照 ,将 14 8例进展期胃癌根治术后患者分为胃肠安组、化疗组和胃肠安加化疗组 (简称中西医组 )。观察 3组患者的生存率、转移率、生存质量和转移复发后带瘤生存时间。结果 :胃肠安组的术后 1、2、3年生存期分别为93 2 3%、79 34%、71 78% ,中西医组分别为 89 5 1%、6 9 77%、5 5 76 % ,明显高于化疗组的 83 86 %、5 9 33%、4 9 4 3% (P <0 0 5 ) ;胃肠安组与中西医组比较差异无显著性。 1、2、3年转移率胃肠安组分别为15 2 5 %、2 8 81%、33 90 % ,中西医组分别为 15 5 2 %、4 1 38%、4 6 5 5 % ,但只有术后 1年转移率胃肠安组及中西医组与化疗组比较 ,差异有显著性 (P <0 0 5 ) ;2、3年转移率差异无显著性 ,但均明显低于化疗组 (分别为 35 4 8% ,4 5 16 % ,5 1 6 1% )。胃肠安组的生存质量和复发转移后的生存时间明显好于化疗组 (P <0 0 5 )。结论 :中药胃肠安对胃癌术后患者的复发转移有防治作用。
英文摘要:
      Objective:To observe the effect of Weichang′an (WCA, a Chinese preparation) in preventing post-operative metastasis of progressive stage of gastric cancer. Methods:A prospective randomized, controlled study was conducted by dividing the 148 patients of progressive staged gastric cancer after radical operation into the WCA group, the chemotherapy (CT) group and the WCA+CT group, to observe the survival rate, metastasis rate, quality of life (QOF) and tumor-bearing survival time after relapse (TST) in patients. Results:The 1-, 2- and 3-year survival rate after operation in the WCA+CT group was 89.51%, 69.77% and 55.76% respectively, which was significantly higher than that in the CT group (83.86%, 59.33% and 49.43%) respectively (P<0 05), but showed insignificant difference as compared with that in the WCA group (93.23%, 79.34% and 71.78%). Only 1-year metastasis in the WCA group was 15.25%, and in the WCA+CT group was 15.52%, the two were significantly lower than that in the CT group (35.48%, P<0 05). But the comparison of 2-year metastasis rate among the 3 groups (28.81%, 41.38% and 45.16%) and 3-year metastasis rate among them (33.90%, 46.55% and 51.61%) were insignificantly different. The QOF and TST were markedly better in the WCA group than those in the CT group. Conclusion:WCA has preventive effect on relapse and metastasis in post-operational gastric cancer patients.
关闭